Preventive strategies for acute kidney injury in cancer patients

L Cosmai, C Porta, M Foramitti, V Perrone… - Clinical Kidney …, 2021 - academic.oup.com
Acute kidney injury (AKI) is a common complication of cancer that occurs in up to 50% of
neoplastic patients during the natural history of their disease; furthermore, it has a huge …

Prevention of cisplatin-induced acute kidney injury: a systematic review and meta-analysis

A Hamroun, R Lenain, JJ Bigna, E Speyer, L Bui… - Drugs, 2019 - Springer
Purpose Cisplatin-induced acute kidney injury (CIA) is a serious adverse event that affects
20–40% of exposed patients, despite any implemented precaution to avoid it. The aim of this …

[HTML][HTML] Cisplatin in liver cancer therapy

S Hamaya, K Oura, A Morishita, T Masaki - International Journal of …, 2023 - mdpi.com
Hepatocellular carcinoma (HCC) is the most common primary liver tumor and is often
diagnosed at an unresectable advanced stage. Systemic chemotherapy as well as …

Urolithin A mitigates cisplatin-induced nephrotoxicity by inhibiting renal inflammation and apoptosis in an experimental rat model

M Guada, R Ganugula, M Vadhanam… - Journal of Pharmacology …, 2017 - ASPET
Cumulative kidney toxicity associated with cisplatin is severe and there is no clear
consensus on the therapeutic management of the same. The pathogenesis involves …

A systematic review for prevention of cisplatin-induced nephrotoxicity using different hydration protocols and meta-analysis for magnesium hydrate supplementation

J Li, Y Wu, C Chen, W Zhang, L Yue, T Liu - Clinical and Experimental …, 2024 - Springer
Background Nephrotoxicity remains the most serious side effect of cisplatin therapy.
Cisplatin-induced nephrotoxicity (CIN) limits the use of this drug and affects up to 20% of …

Protective effect of food derived nutrients on cisplatin nephrotoxicity and its mechanism

C Liu, S Zhou, W Bai, L Shi, X Li - Food & Function, 2022 - pubs.rsc.org
Platinum-based metal complexes, especially cisplatin (cis-diamminedichloroplatinum II,
CDDP), possess strong anticancer properties and a broad anticancer spectrum. However …

Effect of intraoperative dexmedetomidine on renal function after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: a randomized, placebo …

Y Song, DH Kim, TD Kwon, DW Han… - International journal …, 2019 - Taylor & Francis
Introduction: Cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy
(HIPEC) predispose to postoperative renal dysfunction. Dexmedetomidine is an α2 …

Suitability of oral rehydration solution (ORS) for use in the cisplatin short hydration method

Y Saito, Y Takekuma, M Kobayashi… - Anticancer …, 2022 - ar.iiarjournals.org
Background/Aim: Short hydration is a method to change partial intravenous hydration to oral
to administer cisplatin (CDDP); however, the most suitable form of oral hydration is …

[HTML][HTML] The best platinum regimens for chemo-naive incurable non-small cell lung cancer: network meta-analysis

N Horita, A Nagashima, K Nakashima, Y Shibata… - Scientific reports, 2017 - nature.com
Platinum regimens still play a key role in chemotherapy for incurable non-small cell lung
cancer (NSCLC). Although guidelines list many platina regimens, the best regimens have …

Multivariate analysis of risk factors for cisplatin‐induced nephrotoxicity in gynecological cancer

Y Yamamoto, K Watanabe, H Matsushita… - Journal of Obstetrics …, 2017 - Wiley Online Library
Aim Risk factors for cisplatin‐induced nephrotoxicity (CIN) vary by population. This study
aimed to assess risk factors for CIN in patients with gynecological cancer. Methods Patients …